المؤلفون: Harada, Makoto, Han, Siyu, Shi, Mengya, Ge, Jianhong, Yu, Shixiang, Adam, Jonathan, Adamski, Jerzy, Scheerer, Markus F., Neschen, Susanne, de Angelis, Martin Hrabe, Wang-Sattler, Rui

المساهمون: Uehara Memorial Foundation, European Federation of Pharmaceutical Industries and Associations, European Commission, Innovative Medicines Initiative

المصدر: International Journal of Biological Macromolecules ; volume 265, page 130962 ; ISSN 0141-8130

مصطلحات موضوعية: Molecular Biology, General Medicine, Biochemistry, Structural Biology

الإتاحة: https://doi.org/10.1016/j.ijbiomac.2024.130962Test
https://api.elsevier.com/content/article/PII:S0141813024017677?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S0141813024017677?httpAccept=text/plainTest

المؤلفون: Heerspink, Hiddo J. L., Birkenfeld, Andreas L., Cherney, David Z. I., Colhoun, Helen M., Ji, Linong, Mathieu, Chantal, Groop, Per-Henrik, Pratley, Richard E., Rosas, Sylvia E., Rossing, Peter, Skyler, Jay S., Tuttle, Katherine R., Lawatscheck, Robert, Scott, Charlie, Edfors, Robert, Scheerer, Markus F., Kolkhof, Peter, McGill, Janet B.

المساهمون: HUS Abdominal Center, Research Programs Unit, Department of Medicine, Per Henrik Groop / Principal Investigator, Clinicum, Nefrologian yksikkö

مصطلحات موضوعية: Albuminuria, Chronic kidney disease, Finerenone, Type 1 diabetes, 3121 General medicine, internal medicine and other clinical medicine

وصف الملف: application/pdf

العلاقة: The FINE-ONE study is supported by Bayer AG. The sponsor was involved in the study design and the writing of the report.; Heerspink , H J L , Birkenfeld , A L , Cherney , D Z I , Colhoun , H M , Ji , L , Mathieu , C , Groop , P-H , Pratley , R E , Rosas , S E , Rossing , P , Skyler , J S , Tuttle , K R , Lawatscheck , R , Scott , C , Edfors , R , Scheerer , M F , Kolkhof , P & McGill , J B 2023 , ' Rationale and design of a randomised phase III registration trial investigating finerenone in participants with type 1 diabetes and chronic kidney disease : The FINE-ONE trial ' , Diabetes Research and Clinical Practice , vol. 204 , 110908 . https://doi.org/10.1016/j.diabres.2023.110908Test; 15feebc2-b552-43d8-809f-5d7b022a7dae; http://hdl.handle.net/10138/569009Test; 001105271900001

الإتاحة: http://hdl.handle.net/10138/569009Test

المؤلفون: Heerspink, Hiddo J.L., Birkenfeld, Andreas L., Cherney, David Z.I., Colhoun, Helen M., Ji, Linong, Mathieu, Chantal, Groop, Per Henrik, Pratley, Richard E., Rosas, Sylvia E., Rossing, Peter, Skyler, Jay S., Tuttle, Katherine R., Lawatscheck, Robert, Scott, Charlie, Edfors, Robert, Scheerer, Markus F., Kolkhof, Peter, McGill, Janet B.

المصدر: Heerspink , H J L , Birkenfeld , A L , Cherney , D Z I , Colhoun , H M , Ji , L , Mathieu , C , Groop , P H , Pratley , R E , Rosas , S E , Rossing , P , Skyler , J S , Tuttle , K R , Lawatscheck , R , Scott , C , Edfors , R , Scheerer , M F , Kolkhof , P & McGill , J B 2023 , ' Rationale and design of a randomised phase III registration trial investigating finerenone ....

مصطلحات موضوعية: Albuminuria, Chronic kidney disease, Finerenone, Type 1 diabetes

وصف الملف: application/pdf

العلاقة: https://research.rug.nl/en/publications/e11de8c8-c6ce-4bb7-9d74-1542924c85fbTest

الإتاحة: https://doi.org/10.1016/j.diabres.2023.110908Test
https://hdl.handle.net/11370/e11de8c8-c6ce-4bb7-9d74-1542924c85fbTest
https://research.rug.nl/en/publications/e11de8c8-c6ce-4bb7-9d74-1542924c85fbTest
https://pure.rug.nl/ws/files/892743537/Rationale_and_design_of_a_randomised_phase_III_registration_trial_investigating_finerenone_in_participants_with_type_1_diabetes_and_chronic_kidney_disease-_The_FINE-ONE_trial.pdfTest
http://www.scopus.com/inward/record.url?scp=85174661979&partnerID=8YFLogxKTest

المؤلفون: Ruilope, Luis M., Pitt, Bertram, Anker, Stefan D., Rossing, Peter, Kovesdy, Csaba P., Pecoits-Filho, Roberto, Pergola, Pablo, Joseph, Amer, Lage, Andrea, Mentenich, Nicole, Scheerer, Markus F., Bakris, George L.

المصدر: Ruilope , L M , Pitt , B , Anker , S D , Rossing , P , Kovesdy , C P , Pecoits-Filho , R , Pergola , P , Joseph , A , Lage , A , Mentenich , N , Scheerer , M F & Bakris , G L 2023 , ' Kidney outcomes with finerenone : an analysis from the FIGARO-DKD study ' , Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association , vol. 38 , no. 2 , pp. 372-383 . https://doi.org/10.1093/ndt/gfac157Test

مصطلحات موضوعية: albuminuria, chronic kidney disease, finerenone, kidney outcomes, type 2 diabetes

وصف الملف: application/pdf

الإتاحة: https://doi.org/10.1093/ndt/gfac157Test
https://curis.ku.dk/portal/da/publications/kidney-outcomes-with-finerenoneTest(55c29c2e-6c1f-4ba2-93d8-884c18605401).html
https://curis.ku.dk/ws/files/341877359/gfac157.pdfTest

المؤلفون: Harada, Makoto, Adam, Jonathan, Covic, Marcela, Ge, Jianhong, Brandmaier, Stefan, Muschet, Caroline, Huang, Jialing, Han, Siyu, Rommel, Martina, Rotter, Markus, Heier, Margit, Mohney, Robert P., Krumsiek, Jan, Kastenmüller, Gabi, Rathmann, Wolfgang, Zou, Zhongmei, Zukunft, Sven, Scheerer, Markus F., Neschen, Susanne, Adamski, Jerzy

المصدر: Cardiovascular Diabetology; 6/12/2024, Vol. 23 Issue 1, p1-14, 14p

مصطلحات موضوعية: METFORMIN, TYPE 2 diabetes, METABOLITES, BONFERRONI correction, CITRIC acid

المؤلفون: Rossing, Peter, Filippatos, Gerasimos, Agarwal, Rajiv, Anker, Stefan D., Pitt, Bertram, Ruilope, Luis M., Chan, Juliana C.N., Kooy, Adriaan, McCafferty, Kieran, Schernthaner, Guntram, Wanner, Christoph, Joseph, Amer, Scheerer, Markus F., Scott, Charlie, Bakris, George L.

المصدر: FIDELIO-DKD Investigators , Rossing , P , Filippatos , G , Agarwal , R , Anker , S D , Pitt , B , Ruilope , L M , Chan , J C N , Kooy , A , McCafferty , K , Schernthaner , G , Wanner , C , Joseph , A , Scheerer , M F , Scott , C & Bakris , G L 2022 , ' Finerenone in Predominantly Advanced CKD and Type 2 Diabetes With or Without Sodium-Glucose Cotransporter-2 Inhibitor Therapy ' , Kidney International Reports , vol. 7 , no. 1 , ....

مصطلحات موضوعية: albuminuria, chronic kidney disease, finerenone, sodium-glucose cotransporter-2 inhibitors, type 2 diabetes

وصف الملف: application/pdf

العلاقة: https://research.rug.nl/en/publications/ea4fa8e0-f695-4d2f-bf5d-943c8a58ad30Test

الإتاحة: https://doi.org/10.1016/j.ekir.2021.10.008Test
https://hdl.handle.net/11370/ea4fa8e0-f695-4d2f-bf5d-943c8a58ad30Test
https://research.rug.nl/en/publications/ea4fa8e0-f695-4d2f-bf5d-943c8a58ad30Test
https://pure.rug.nl/ws/files/200402268/1_s2.0_S2468024921014674_main.pdfTest

المؤلفون: Agarwal, Rajiv, Anker, Stefan D., Filippatos, Gerasimos, Pitt, Bertram, Rossing, Peter, Ruilope, Luis M., Boletis, John, Toto, Robert, Umpierrez, Guillermo E., Wanner, Christoph, Wada, Takashi, Scott, Charlie, Joseph, Amer, Ogbaa, Ike, Roberts, Luke, Scheerer, Markus F., Bakris, George L., FIDELIO-DKD investigators

المساهمون: Medicine, School of Medicine

المصدر: PMC

مصطلحات موضوعية: CREDENCE, FIDELIO-DKD, Canagliflozin, Cardiorenal, Finerenone

وصف الملف: application/pdf

العلاقة: Nephrology Dialysis Transplantation; Agarwal R, Anker SD, Filippatos G, et al. Effects of canagliflozin versus finerenone on cardiorenal outcomes: exploratory post hoc analyses from FIDELIO-DKD compared to reported CREDENCE results. Nephrol Dial Transplant. 2022;37(7):1261-1269. doi:10.1093/ndt/gfab336; https://hdl.handle.net/1805/40405Test

الإتاحة: https://doi.org/10.1093/ndt/gfab336Test
https://hdl.handle.net/1805/40405Test

المؤلفون: Rossing, Peter, Anker, Stefan D., Filippatos, Gerasimos, Pitt, Bertram, Ruilope, Luis M., Birkenfeld, Andreas L., McGill, Janet B., Rosas, Sylvia E., Joseph, Amer, Gebel, Martin, Roberts, Luke, Scheerer, Markus F., Bakris, George L., Agarwal, Rajiv

المصدر: Rossing , P , Anker , S D , Filippatos , G , Pitt , B , Ruilope , L M , Birkenfeld , A L , McGill , J B , Rosas , S E , Joseph , A , Gebel , M , Roberts , L , Scheerer , M F , Bakris , G L & Agarwal , R 2022 , ' Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment : The FIDELITY Analysis ' , Diabetes Care , vol. 45 , no. 12 , pp. 2991-2998 ....

وصف الملف: application/pdf

الإتاحة: https://doi.org/10.2337/dc22-0294Test
https://curis.ku.dk/portal/da/publications/finerenone-in-patients-with-chronic-kidney-disease-and-type-2-diabetes-by-sodiumglucose-cotransporter-2-inhibitor-treatmentTest(c6576527-178f-47a6-8157-2779f7348608).html
https://curis.ku.dk/ws/files/329295150/dc220294.pdfTest

المؤلفون: Agarwal, Rajiv, Anker, Stefan D., Filippatos, Gerasimos, Pitt, Bertram, Rossing, Peter, Ruilope, Luis M., Boletis, John, Toto, Robert, Umpierrez, Guillermo E., Wanner, Christoph, Wada, Takashi, Scott, Charlie, Joseph, Amer, Ogbaa, Ike, Roberts, Luke, Scheerer, Markus F., Bakris, George L.

المصدر: Agarwal , R , Anker , S D , Filippatos , G , Pitt , B , Rossing , P , Ruilope , L M , Boletis , J , Toto , R , Umpierrez , G E , Wanner , C , Wada , T , Scott , C , Joseph , A , Ogbaa , I , Roberts , L , Scheerer , M F , Bakris , G L & FIDELIO-DKD Investigators 2022 , ' Effects of canagliflozin versus finerenone on cardiorenal outcomes : exploratory post hoc analyses from FIDELIO-DKD compared to reported CREDENCE results ' ....

مصطلحات موضوعية: canagliflozin, cardiorenal, CREDENCE, FIDELIO-DKD, finerenone, CHRONIC KIDNEY-DISEASE, CARDIOVASCULAR OUTCOMES

وصف الملف: application/pdf

الإتاحة: https://doi.org/10.1093/ndt/gfab336Test
https://curis.ku.dk/portal/da/publications/effects-of-canagliflozin-versus-finerenone-on-cardiorenal-outcomesTest(b66dfc9f-c534-4b3d-868c-d57fd09161e2).html
https://curis.ku.dk/ws/files/313705626/gfab336.pdfTest

المؤلفون: Ruilope, Luis M, Pitt, Bertram, Anker, Stefan D, Rossing, Peter, Kovesdy, Csaba P, Pecoits-Filho, Roberto, Pergola, Pablo, Joseph, Amer, Lage, Andrea, Mentenich, Nicole, Scheerer, Markus F, Bakris, George L

المساهمون: Bayer AG, FIGARO-DKD

المصدر: Nephrology Dialysis Transplantation ; volume 38, issue 2, page 372-383 ; ISSN 0931-0509 1460-2385

مصطلحات موضوعية: Transplantation, Nephrology

الإتاحة: https://doi.org/10.1093/ndt/gfac157Test
https://academic.oup.com/ndt/article-pdf/38/2/372/49167530/gfac157.pdfTest